Reported book
$1.1B
13F equity value
Institutional filer · SEC 13F · Q2 2024
Logos Global Management LP
The reported 13F portfolio of Logos Global Management LP (CIK 1792126) - top holdings, how concentrated the book is, and what changed last quarter.
- $1.1B
- Reported book
- 53
- Positions
- #65
- of 360 filers
The verdict
Logos Global Management LP runs a large institutional book - $1.1B across 53 reported positions as of Q2 2024, a moderately concentrated portfolio.
- $1.1B
- reported 13F value
- 53
- disclosed positions
- 16.9%
- in SPDR SER TR
- #65
- of 360 filers
Reflects long US-equity positions reported to the SEC as of Q2 2024; 13F excludes shorts, cash, non-US and most derivatives, so this is not total AUM.
How to read this page
This page reconstructs an institutional manager's reported equity portfolio from its quarterly SEC Form 13F-HR filings. Any investment manager with at least $100 million in qualifying US-listed equity assets must file a 13F with the Securities and Exchange Commission within 45 days of each quarter-end, disclosing the long positions it held on the last day of that quarter. The "reported book" shown here is the total market value of those disclosed positions, it is not the firm's total assets under management, because 13F covers only long US-listed equities and a defined set of options and convertibles. Short positions, cash, private holdings, sovereign debt, most fixed income, non-US equities, and derivatives are all excluded by rule, so a manager's true economic exposure can differ materially from what appears here. "Positions" counts the distinct securities disclosed; "% of book" shows how much weight each holding carries. Treat these figures as a quarter-lagged snapshot for understanding how a manager is positioned - not as live holdings or investment advice. Each line traces back to a specific filing on SEC EDGAR. This page is provided for informational purposes only and is not financial advice, consult a licensed financial advisor before making investment decisions.
Positions
53
Disclosed securities
Top-5 weight
39%
Of reported book
Largest position
16.9%
SPDR SER TR
Core + tail
Top-5 position weight
Top-5 position weight 39.2%
The five largest positions make up about 39% of Logos Global Management LP's reported book as of Q2 2024.
Top Reported Holdings
| # | Security | Value | % of book |
|---|---|---|---|
| 1 | SPDR SER TR | $185.4M | 16.9% |
| 2 | APELLIS PHARMACEUTICALS INC | $76.7M | 7.0% |
| 3 | IDEAYA BIOSCIENCES INC | $59.7M | 5.4% |
| 4 | ARGENX SE | $58.1M | 5.3% |
| 5 | MERUS N V | $50.3M | 4.6% |
| 6 | REVOLUTION MEDICINES INC | $46.6M | 4.2% |
| 7 | DISC MEDICINE INC | $41.7M | 3.8% |
| 8 | OCULAR THERAPEUTIX INC | $35.2M | 3.2% |
| 9 | OLEMA PHARMACEUTICALS INC | $34.7M | 3.2% |
| 10 | VERA THERAPEUTICS INC | $34.4M | 3.1% |
| 11 | MOONLAKE IMMUNOTHERAPEUTICS | $33.0M | 3.0% |
| 12 | JANUX THERAPEUTICS INC | $31.4M | 2.9% |
| 13 | XENCOR INC | $28.4M | 2.6% |
| 14 | SILENCE THERAPEUTICS PLC | $28.0M | 2.5% |
| 15 | SAREPTA THERAPEUTICS INC | $23.7M | 2.2% |
| 16 | AKERO THERAPEUTICS INC | $18.8M | 1.7% |
| 17 | STRUCTURE THERAPEUTICS INC | $17.7M | 1.6% |
| 18 | DESIGN THERAPEUTICS INC | $16.9M | 1.5% |
| 19 | ANNEXON INC | $16.2M | 1.5% |
| 20 | IMMUNOVANT INC | $15.2M | 1.4% |
| 21 | NUVALENT INC | $14.8M | 1.4% |
| 22 | XENON PHARMACEUTICALS INC | $14.6M | 1.3% |
| 23 | IONIS PHARMACEUTICALS INC | $14.3M | 1.3% |
| 24 | STOKE THERAPEUTICS INC | $14.2M | 1.3% |
| 25 | ERASCA INC | $13.9M | 1.3% |
Latest Quarter Trades · Q2 2024
New positions (53)
SPDR SERIES TRUST $185.4M
APELLIS PHARMACEUTICALS INC $76.7M
IDEAYA BIOSCIENCES INC $59.7M
ARGENX SE $58.1M
MERUS N V $50.3M
REVOLUTION MEDICINES INC $46.6M
Reading Logos Global Management LP's book
A concentrated core with a diversified tail.
- Open any holding to see who else owns it and how concentrated that stock is. Browse stocks
- Compare this manager against the largest 13F filers by book size. Top funds by AUM
- Remember 13F shows long positions only, not total AUM, shorts or non-US holdings. 13F limitations
Informational only, not investment advice. 13F is a 45-day-lagged quarterly snapshot; positions may have changed since the filing date.
Frequently Asked Questions
How big is Logos Global Management LP's 13F portfolio?▼
Logos Global Management LP reports $1.1B of long US-equity positions across 53 securities as of Q2 2024. This reflects 13F-disclosed holdings only, it is not the firm's total assets under management.
What is Logos Global Management LP's largest position?▼
Logos Global Management LP's largest reported position is SPDR SER TR at $185.4M, about 16.9% of its reported book as of Q2 2024.
What did Logos Global Management LP trade last quarter?▼
In its Q2 2024 filing, Logos Global Management LP opened 53 new positions. Each change is drawn from a line in the firm's 13F-HR filing and can be verified on SEC EDGAR.
Where does Logos Global Management LP's holdings data come from?▼
Every figure renders live from Logos Global Management LP's SEC Form 13F-HR filings in EDGAR, a mandatory quarterly disclosure of long US-listed equity positions, filed within 45 days of quarter-end.
Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q2 2024 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Reported value is not total AUM.